Tamara Minko

Professor II and Chair

Department of Pharmaceutics

Invited and Plenary Lectures and Seminars

  1. "Nanotechnology Strategies to Overcome Multidrug Resistance", School of Pharmacy, Oregon State University, Corvallis, OR, April 19, 2012
  2. "Cancer Stem Cells Specific Therapy: Targeted Nanomedicine for Simultaneous Suppression of CD44 Protein and Cell Death Induction", 9th International Conference and Workshop on Biological Barriers, Saarbrucken, Germany, March 6, 2012.
  3. "Molecular Targeting of Drug Delivery Systems to Cancer", Nanomedicine Research Center, Cedars-Sinai Medical Center, Los Angeles, CA, November 16, 2011.
  4. "Nanotechnology Strategies to Overcome Limitations in Cancer Treatment", Department of Pharmaceutical Sciences at the University at Buffalo, The State University of New York, October 6, 2011.
  5. "Combination of Tumor-Targeted Chemo- and Gene Therapy for Treatment of Primary Ovarian Cancer and Prevention of Metastases", Ovarian Cancer Symposium:  One Force to Make a Difference , June 18, 2011, Princeton, NJ.
  6. "Multifunctional and Multicomponent Drug Delivery Systems for Cancer Treatment and Imaging", The 2011 Annual Retreat on Cancer Research in New Jersey, May 26, 20011, Piscataway, NJ
  7. "Nanotechnology Strategies to Overcome Limitations in Drug Delivery: Opportunities and Challenges", The Eighth International Nanomedicine and Drug Delivery Symposium, October 3, 2010, Omaha, NE.
  8. "Molecular Targeting of Drug Delivery Systems to Cancer", Gordon Research Conferences: Drug Carriers in Medicine and Biology, August 17, 2010, Waterville Valley, NH. 
  9. "Nanotechnology Strategies to Overcome Limitations in Cancer Treatment", Particles 2010: Medical/Biochemical Diagnostic, Pharmaceutical, and Drug Delivery Applications of Particle Technology, May 23, 2010, Lake Buena Vista, FL.
  10. "Nanotechnology Strategies to Overcome Limitations in Cancer Chemotherapy", Department of Pharmaceutical Sciences, Wayne State University, April 28, 2010, Detroit, MI.
  11. "Nanotechnology Strategies to Overcome Limitations in Drug Delivery: Opportunities and Challenges", New York Society of Cosmetic Chemists (NYSCC) Spring Seminar, April 21, 2010, West Orange NJ.
  12. "Nanotechnology Strategies to Overcome Limitations in Drug Delivery: Opportunities and Challenges", Clinical Applications of Quantum Dot and Nanoparticle Technology, University of Illinois at Chicago Center for Clinical and Translational Science (CCTS), April 13, 2010, Chicago, IL.
  13. "Mechanisms of Cellular Drug Resistance and Strategies to Overcome It", Symposium on Biomedical Polymers for Drug Delivery, March 27, 2010, Salt Lake City, UT.
  14. "Nanotechnology Strategies to Overcome Limitations in Drug Delivery: Opportunities and Challenges", University of Wisconsin, March 17, 2010, Madison, WI.
  15. "Nanotechnology Strategies to Overcome Limitations in Cancer Chemotherapy", F. Hoffmann-La Roche Ltd, January 29, 2010, Nutley, NJ.
  16. "New horizons in treatment of lung cancer: Combinatorial liposomal inhalation delivery of drugs and suppressors of cellular resistance", Liposome advances: Recent trends and progress, December 13, 2009, London, UK. 
  17. "Targeted multifunctional nanocarriers for tumor treatment and imaging", Annual Meeting of the American Association of Pharmaceutical Scientists, November 11, 2009, Los Angeles, CA. 
  18. "Inhalatory co-delivery of anticancer drugs and antisense oligonucleotides/siRNA for lung cancer treatment", 35th Annual Meeting of the Controlled Release Society, July 22, 2009, Copenhagen, Denmark. 
  19. "Nanotechnology Strategies to Overcome Limitations in Drug Delivery: Opportunities and Challenges", 41st Annual Pharmaceutics Graduate Student Research Meeting "Globalization of the Pharmaceutical Industry", June 26, 2009, Purdue University, West Lafayette, IN. 
  20. "Nanotechnology Strategies to Overcome Limitations in Drug Delivery: Opportunities and Challenges", AAPS Workshop on Evolving Science and Technology in Physical Pharmacy and Biopharmaceutics, May 15, 2009, Baltimore, MD. 
  21. "Receptor Targeted Nanocarriers for Tumor-Specific Treatment and Imaging", 14th International Symposium on Recent Advances in Drug Delivery Systems, February 18, 2009, Salt Lake City, UT. 
  22. "Multifunctional Nanotherapeutics for Cancer Treatment", American Association for Cancer Research - American Chemical Society Joint Conference on: Chemistry in Cancer Research: A Vital Partnership in Drug Discovery and Development, February 10, 2009, New Orleans, LA.
  23. "Receptor Targeted Nanocarriers for Tumor-Specific Treatment and Imaging", The Provost Interdisciplinary Seminar Series on Targeted Therapeutics and Drug Delivery Systems, The University of Pennsylvania School of Medicine, Philadelphia, PA, January 14, 2009.
  24. "Receptor-targeted nanocarriers for tumor-specific treatment and imaging", Birck Nanotechnology Center, Purdue University, West Lafayette, IN, December 11, 2008.
  25. “Efficient Co-Delivery of siRNA/Antisense Oligonucleotides and Drug for Lung Cancer Treatment”, 36th Annual Scientific Session of the New Jersey Thoracic Society, New Brunswick, NJ, June 6, 2008.
  26. “Nanocarriers for Tumor-Targeted Drug Delivery”, 2008 NSTI Nanotech 2008 11th Annual Meeting, NCI/NSTI Special Symposium on Nanotechnology for Cancer Prevention, Diagnosis and Treatment, Boston, MA, June 4, 2008.
  27. “Targeted Multifunctional Nanocarriers for Tumor Treatment and Imaging”, School of Pharmacy, University of Rhode Island, Kingston, RI, May 15, 2008.
  28. “Targeted MultifunctionalNanocarriers for Tumor Treatment and Imaging” in the 2nd Annual Meeting “Toward the Development of Drug Delivery Systems”, Perugia, Italy, March 7, 2008.
  29. “Targeted Multifunctional Nanocarriers for Intracellular Drug Delivery” at the School of Pharmacy, University of Ferrara, Ferrara, Italy, March 5, 2008.
  30. “Tumor – Targeted Anticancer Prodrugs”, Annual Meeting of the American Association of Pharmaceutical Scientists, San Diego, CA, November 15, 2007.
  31. “Targeted Multicomponent Nanocarriers for Cancer Treatment and Diagnostics”, The Fifth International Nanomedicine and Drug Delivery Symposium, Boston, MA, November 2, 2007.
  32. “Multifunctional Drug Delivery System for Inhalatory Treatment of Lung Cancer”, The Biennial New Jersey Pharmaceutical Conference of 2007, New Brunswick, NJ, October 5, 2007.
  33. “Targeted Multifunctional Nanocarriers for Intracellular Drug Delivery”, Department of Pharmaceutics at the University of Minnesota, Minneapolis, MN, September 20, 2007.
  34. “Targeted multicomponent nanocarriers in cancer treatment”, the 6th Annual Meeting of the Israeli Chapter of the Controlled Release Society on September 5, 2007, Cesaria, Israel.
  35. “Targeted multifunctional drug delivery systems for cancer treatment and imaging” Chemistry and Chemical Biology Department at Stevens Institute of Technology, Hoboken, NJ., September 12, 2007.
  36. “Tumor-specific targeting of drug delivery systems for cancer therapy and imaging”, 34th Annual Meeting of the Controlled Release Society, Long Beach, CA, July 11, 2007.
  37. “Complex liposomal drug delivery system for inhalatory treatment of lung cancer”, 35th Annual Scientific Session of the New Jersey Thoracic Society, New Brunswick, NJ, June 1, 2007.
  38. “Targeted Multifunctional Nanocarriers for Intracellular Drug Delivery”, Department of Chemistry, Newark, Rutgers, The State University of New Jersey, Newark, NJ, March 30, 2007.
  39. “Receptor Targeting of Polymer Therapeutics and Imaging Agents to Tumor”, International Symposium on Polymer Therapeutics ISPT-07, Berlin, Germany, February 20, 2007.
  40. “Tumor-Specific Targeting of Drug Delivery Systems”, Novartis Pharmaceuticals, East Hanover, NJ, November 17, 2006.
  41. Targeted Nanocarriers for Intracellular Drug Delivery, Targeted Nanocarriers and Therapeutics, Institute for Translational Medicine and Therapeutics, The University of Pennsylvania School of Medicine, Philadelphia, PA, November 16, 2006.
  42. “Tumor - Targeting Liposomal Complex for Short Interfering RNA Delivery”, Georgetown University Medical Center, Washington DC, October 24, 2006.
  43. “Targeted Polymeric Prodrug with Multivalent Components for Cancer Therapy”, the 7th International Biorelated Polymers Symposium at the 232nd American Chemical Society Meeting, San Francisco, CA, September 12, 2006.
  44. “Molecular targeting of drug delivery system to lung cancer”, 34th Annual Scientific Session of New Jersey Thoracic Society, New Brunswick, NJ, June 2, 2006.
  45. “Targeted Proapoptotic Drug Delivery System for Chemotherapy of Ovarian Cancer”, The Cancer Institute of New Jersey, New Brunswick, NJ, May 5, 2006.
  46. “Extracellular and intracellular molecular targeting of drug delivery system to cancer”, College of Pharmacy, University of Nebraska Medical Center, Omaha, NE, March 31, 2006.
  47. “Targeted anticancer polymeric prodrugs”, Abbott Laboratories, Abbott Park, IL, March 23, 2006.
  48. “Complex drug delivery composition for treating cancer”, Department of Pharmaceutics and Pharmaceutical Chemistry, University of Utah, Salt Lake City, UT, February 27, 2006.
  49. “Advances in targeted drug delivery for cancer treatment”, Bristol-Myers Squibb Co., New Brunswick, NJ, February 3, 2006.
  50. “Targeted drug delivery systems for cancer therapy”, Department of Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago IL, January 11, 2006.
  51. “Advanced targeted drug delivery systems for cancer therapy”, International Conference on Advances in Pharmaceutical Research and Technology, Mumbai, India, November 25-29, 2005.
  52. “Novel approaches in anticancer drug delivery”, The Biennial New Jersey Pharmaceutical Conference of 2005 “Contribution of Women in the Pharmaceutical Sciences”, East Brunswick, NJ, October 6, 2005.
  53. “Delivery system for remediation of cellular hypoxic damage”, Third International Nanomedicine and Drug Delivery Symposium, Baltimore, MD, September 26-27, 2005.
  54. “Molecular targeting of drug delivery systems to cancer”, College of Pharmacy, Howard University, Washington, DC, November 4, 2004.
  55. “Targeted delivery of anticancer drugs and peptides by polyethylene glycol conjugates”, 7th Symposium on Biomaterials Science, New Brunswick, NJ, October 21-22, 2004.
  56. “Extracellular and intracellular molecular targeting of drug delivery system to cancer cells”, World Conference on Dosing of Antiinfectivnes – Dosing the Magic Bullets, Nurnberg, Germany, September 9-11, 2004.
  57. “A novel multicomponent delivery system to enhance the efficacy of lung cancer therapy”, 32nd Annual Scientific Section of the New Jersey Thoracic Society, New Brunswick, NJ, June 4, 2004.
  58. “Targeted proapoptotic anticancer drug delivery system”, College of Pharmacy, University of Maryland, Baltimore, MD, March 3, 2004.
  59. “Molecular targeting of drug delivery systems to cancer cells by peptides and antisense oligonucleotides”, College of Pharmacy, University of Kentucky, Lexington, KY, February 27, 2004.
  60. “Molecular targeting of cellular resistance in cancer”, 8th World Congress on Advances in Oncology and 6th International Symposium on Molecular Medicine, Crete, Greece, October 16, 2003.
  61. “Multicomponent drug delivery system for enhancing the efficacy of cancer chemotherapy”, Meeting of the New Jersey Center for Biomaterials, New Brunswick, NJ, September 17, 2003.
  62. “Molecular targeting of drug delivery systems to cancer cells by peptides and antisense oligonucleotides”, Department of Biopharmaceutical Sciences, University of Illinois at Chicago, Chicago IL, April 2, 2003.
  63. “Genetic adaptation to life at high altitude: Adaptation to chronic hypoxia, relevance to disease at sea level”, University of Lima, Lima, Peru, March 14, 2003.
  64. “Advanced targeted drug delivery systems for cancer therapy”, Myriad Genetics, Inc., Salt Lake City, UT, March 4, 2003.
  65. “Molecular targeting of drug delivery systems to cancer cells by peptides and antisense oligonucleotides”, EOHSI, Piscataway, NJ, February 6, 2003.
  66. “Targeted proapoptotic drug delivery systems in cancer chemotherapy”, 7th World Congress on Advances in Oncology and 5th International Symposium on Molecular Medicine, Hersonissos, Crete, Greece, October 11, 2002.
  67. “Targeted proapoptotic drug delivery systems in cancer chemotherapy”, Cancer Institute of New Jersey (Breast Cancer Research Program), New Brunswick, NJ, May 2002.
  68. “Advanced drug delivery systems in cancer chemotherapy”, The Screening Technologies Branch of the Developmental Therapeutics Program in Drug Discovery and Development, National Cancer Institute, Frederick, MD, March 2002.
  69. “Novel drug delivery systems for cancer therapy”, Salvona, Dayton, NJ, January 2002.
  70. “Enhancing the efficacy of chemotherapeutic drugs by the suppression of antiapoptotic cellular defense”, GPCC Retreat, The Center for Advanced Biotechnology and Medicine, UMDNJ, Piscataway, NJ, December 2001.
  71. “Advanced drug delivery systems in cancer chemotherapy”, VectraMed, Princeton, NJ, December 2001.
  72. “Enhancing the efficacy of anticancer drugs using multicomponent advanced drug delivery system”, The Cancer Institute of New Jersey, New Brunswick, NJ, December 2001.
  73. “Advanced drug delivery systems in cancer chemotherapy”, Pharmaceutics Conference 2001, East Brunswick, NJ, November 2001.
  74. A polymer drug delivery system for cancer therapy, New Jersey Center for Biomaterials, Piscataway, NJ, June 1, 2001.
  75. Antitumor activity and cell death signaling pathway of free and polymer-bound doxorubicin. The PH 890, Pharmacy Seminar (Pharmaceutics, Spring 2001), Philadelphia College of Pharmacy, University of the Science, Philadelphia, PA, April 27, 2001.
  76. Mechanisms of anticancer action of HPMA copolymer-bound doxorubicin, ENZON, Inc., Piscataway, NJ, November 16, 2000.
  77. Mechanism of anticancer action of HPMA copolymer-bound doxorubicin, 40th Microsymposium "Polymers in Medicine", Czech Republic, July 2000, Special Lecture #4.

Department of Pharmaceutics, Ernest Mario School of Pharmacy

Rutgers, The State University of New Jersey
160-Frelinghuysen Road, Piscataway, NJ 08854-8022, USA.
Tel: (732) 445-3831*214; Fax: (732) 445-3134
For questions or suggestions on this site, please e-mail us.

Rutgers Home

School of Pharmacy

Department Home

Pharmaceutical Science

Minko Lab Home

 

getadobe